Pharmaceutical Companies Release Negative Trial Results On A More Regular Basis
November 7th, 2007 by 
Barry - Admin BioPharmArena
A new study released by Cutting Edge Information, available at http://www.PharmaPublicationStrategy.com, examines medical publication efforts of pharmaceutical companies across a wide range of therapeutic areas. The study finds that, in response to legislation and pressure from the general public, pharmaceutical companies are now more regularly releasing both positive and negative results of their trials.
Rather than toss out adverse trial outcomes, pharmaceutical companies make them public both through traditional academic journals and through other mediums, such as http://www.clinicaltrials.gov, an online registry for clinical trials. Although regulatory scrutiny plays a role in this publication practice, concerns from the general public — payers, physicians, and ultimately the patients themselves — especially encourage openness.
“Companies find it worthwhile to release complete trial results, whether positive or negative,” says Amanda Zuniga, a senior research analyst at Cutting Edge Information. “Doing so shows the public that a company is acting in an honest, transparent manner.” In addition, most companies adhere to one or more sets of publication guidelines that encourage frankness and full disclosure of clinical performance.
Posted in News, Clinical Research and Clincal Trials | 